miR-21 and miR-146a: The microRNAs of inflammaging and age-related diseases
The first paper on “inflammaging” published in 2001 paved the way for a unifying theory on
how and why aging turns out to be the main risk factor for the development of the most …
how and why aging turns out to be the main risk factor for the development of the most …
[HTML][HTML] Turning 21: induction of miR-21 as a key switch in the inflammatory response
FJ Sheedy - Frontiers in immunology, 2015 - frontiersin.org
miR-21 is one of the most highly expressed members of the small non-coding microRNA
family in many mammalian cell types. Its expression is further enhanced in many diseased …
family in many mammalian cell types. Its expression is further enhanced in many diseased …
The role of miRNA in tumor immune escape and miRNA-based therapeutic strategies
Z Zhang, Q Huang, L Yu, D Zhu, Y Li, Z Xue… - Frontiers in …, 2022 - frontiersin.org
Tumor immune escape is a critical step in the malignant progression of tumors and one of
the major barriers to immunotherapy, making immunotherapy the most promising …
the major barriers to immunotherapy, making immunotherapy the most promising …
MyD88 mediates colorectal cancer cell proliferation, migration and invasion via NF‑κB/AP‑1 signaling pathway
G Zhu, Z Cheng, Y Huang… - International …, 2020 - spandidos-publications.com
The role of myeloid differentiation factor 88 (MyD88) in malignant tumors is largely unknown.
Therefore, in this study, we aimed to examine the function and underlying mechanism of …
Therefore, in this study, we aimed to examine the function and underlying mechanism of …
Pooled clustering of high-grade serous ovarian cancer gene expression leads to novel consensus subtypes associated with survival and surgical outcomes
Purpose: Here we assess whether molecular subtyping identifies biological features of
tumors that correlate with survival and surgical outcomes of high-grade serous ovarian …
tumors that correlate with survival and surgical outcomes of high-grade serous ovarian …
miR‐146a Attenuates Inflammatory Pathways Mediated by TLR4/NF‐κB and TNFα to Protect Primary Human Retinal Microvascular Endothelial Cells Grown in High …
EA Ye, JJ Steinle - Mediators of inflammation, 2016 - Wiley Online Library
Pathological mechanisms underlying diabetic retinopathy are still not completely
understood. Increased understanding of potential cellular pathways responsive to …
understood. Increased understanding of potential cellular pathways responsive to …
[HTML][HTML] MicroRNA roles in the nuclear factor kappa B signaling pathway in cancer
J Wu, J Ding, J Yang, X Guo, Y Zheng - Frontiers in Immunology, 2018 - frontiersin.org
Nuclear factor kappa B (NF-κB) is a pluripotent and crucial dimer transcription factor that
orchestrates various physiological and pathological processes, especially cell proliferation …
orchestrates various physiological and pathological processes, especially cell proliferation …
TLR4/MyD88 signaling determines the metastatic potential of breast cancer cells
K Wu, H Zhang, Y Fu, Y Zhu… - Molecular …, 2018 - spandidos-publications.com
The influence of Toll‑like receptor (TLR) 4/myeloid differentiation factor (MyD) 88 signaling
on the invasion and metastasis of cancer cells has been previously reported. The purpose of …
on the invasion and metastasis of cancer cells has been previously reported. The purpose of …
The toll-like receptor 4 polymorphism Asp299Gly is associated with an increased risk of ovarian cancer
KD Kania, D Haręża, JR Wilczyński, M Wilczyński… - Cells, 2022 - mdpi.com
Ovarian cancer (OC) is one of the most common cancers threatening women's lives around
the world. Epithelial ovarian tumors represent the most common ovarian neoplasms. Most …
the world. Epithelial ovarian tumors represent the most common ovarian neoplasms. Most …
A novel serum microRNA panel to discriminate benign from malignant ovarian disease
Ovarian cancer is the seventh most common cancer in women and the most frequent cause
of gynaecological malignancy-related mortality in women. Currently, no standardized …
of gynaecological malignancy-related mortality in women. Currently, no standardized …